Showing results (621-630 of 2,688) with videos related to
Sort By:
Pageof 269
The Lancet. Infectious Diseases|May 3, 2024
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal studySonia Ares-Gómez, Narmeen Mallah, María-Isolina Santiago-Pérez, et al.The Lancet. Infectious Diseases|October 6, 2023
Boostability after single-visit pre-exposure prophylaxis with rabies vaccine: a randomised controlled non-inferiority trialLisanne A Overduin, Jan Pieter R Koopman, Corine Prins, et al.The Lancet. Infectious Diseases|October 1, 2023
Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trialWilliam H K Schilling, Podjanee Jittamala, James A Watson, et al.The Lancet. Infectious Diseases|September 30, 2023
Effectiveness of long-lasting insecticidal nets with pyriproxyfen-pyrethroid, chlorfenapyr-pyrethroid, or piperonyl butoxide-pyrethroid versus pyrethroid only against malaria in Tanzania: final-year results of a four-arm, single-blind, cluster-randomised trialJacklin F Mosha, Nancy S Matowo, Manisha A Kulkarni, et al.The Lancet. Infectious Diseases|October 3, 2024
Estimates of the burden of human rabies deaths and animal bites in India, 2022-23: a community-based cross-sectional survey and probability decision-tree modelling studyJeromie Wesley Vivian Thangaraj, Navaneeth S Krishna, Shanmugasundaram Devika, et al.The Lancet. Infectious Diseases|September 21, 2024
Temporary adaptations to sexual behaviour during the mpox outbreak in 23 countries in Europe and the Americas: findings from a retrospective cross-sectional online surveyMateo Prochazka, Pietro Vinti, Ana Hoxha, et al.The Lancet. Infectious Diseases|September 14, 2024
Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling studyTimothy W Russell, Hermaleigh Townsley, Joel Hellewell, et al.The Lancet. Infectious Diseases|September 29, 2024
Advancing the chemotherapy of tuberculous meningitis: a consensus viewSean Wasserman, Joseph Donovan, Evelyne Kestelyn, et al.The Lancet. Infectious Diseases|September 8, 2024
Safety and immunogenicity of mRNA-based seasonal influenza vaccines formulated to include multiple A/H3N2 strains with or without the B/Yamagata strain in US adults aged 50-75 years: a phase 1/2, open-label, randomised trialDenise Hsu, Akila Jayaraman, Alicia Pucci, et al.The Lancet. Infectious Diseases|June 8, 2023
Leveraging lessons from the COVID-19 pandemic to strengthen low-income and middle-income country preparedness for future global health threatsAyoade AlakijaPageof 269